iPLEDGE program - Wikipedia
https://en.wikipedia.org/wiki/IPLEDGE_program
The iPLEDGE program is a program by the U.S. Food and Drug Administration (FDA) for managing the risk of isotretinoin (also known as Accutane), a prescription medication used for the treatment of acne. Patients, their doctors and their pharmacists are required by the FDA to register and use the iPLEDGE web site in order to receive, prescribe or dispense isotretinoin. Launched: 2006; 16 years ago Commercial: no Type of site: Regulatory/Government
Launched: 2006; 16 years ago
Commercial: no
Type of site: Regulatory/Government
DA: 75 PA: 62 MOZ Rank: 65